BENJAMIN R YERXA, the President of $IRD, sold 7,429 shares of the company on 07-23-2026 for an estimated $22,064. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.0% of their shares of this class of stock. Following this trade, they now own 704,106 shares of this class of $IRD stock.
$IRD Insider Trading Activity
$IRD insiders have traded $IRD stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $IRD stock by insiders over the last 6 months:
- FIGHTING BLINDNESS RETINAL DEGENERATION FUND FOUNDATION sold 1,700,000 shares for an estimated $7,394,999
- GEORGE MAGRATH (Chief Executive Officer) has made 0 purchases and 3 sales selling 43,424 shares for an estimated $204,899.
- ROBERT E. GAGNON (Chief Financial Officer) has made 0 purchases and 2 sales selling 15,625 shares for an estimated $63,599.
- BENJAMIN R YERXA (President) has made 0 purchases and 2 sales selling 14,899 shares for an estimated $61,185.
- ASHWATH JAYAGOPAL (Chief Scientific & Dev. Ofc.) has made 0 purchases and 2 sales selling 11,261 shares for an estimated $58,201.
- JOSEPH K SCHACHLE (Chief Operating Officer) has made 0 purchases and 3 sales selling 13,060 shares for an estimated $57,697.
- RABOURN AMY ZAREMBA (Head of Fin. Quality Assurance) has made 0 purchases and 2 sales selling 4,457 shares for an estimated $23,309.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$IRD Hedge Fund Activity
We have seen 38 institutional investors add shares of $IRD stock to their portfolio, and 19 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CALIGAN PARTNERS LP added 6,075,028 shares (+inf%) to their portfolio in Q1 2026, for an estimated $27,641,377
- ADAGE CAPITAL PARTNERS GP, L.L.C. added 5,074,779 shares (+531.4%) to their portfolio in Q1 2026, for an estimated $23,090,244
- NANTAHALA CAPITAL MANAGEMENT, LLC removed 3,100,000 shares (-64.8%) from their portfolio in Q1 2026, for an estimated $14,105,000
- BOXER CAPITAL MANAGEMENT, LLC added 2,250,000 shares (+inf%) to their portfolio in Q1 2026, for an estimated $10,237,500
- MARSHALL WACE, LLP added 2,155,732 shares (+1367.4%) to their portfolio in Q1 2026, for an estimated $9,808,580
- ADAR1 CAPITAL MANAGEMENT, LLC added 1,809,004 shares (+4522.5%) to their portfolio in Q1 2026, for an estimated $8,230,968
- WOODLINE PARTNERS LP added 1,354,030 shares (+inf%) to their portfolio in Q1 2026, for an estimated $6,160,836
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$IRD Revenue
$IRD had revenues of $2.2M in Q1 2026. This is a decrease of -50.64% from the same period in the prior year.
You can track IRD financials on Quiver Quantitative's IRD stock page.
You can access data on IRD stock through the Quiver Quantitative API.
$IRD Price Targets
Multiple analysts have issued price targets for $IRD recently. We have seen 10 analysts offer price targets for $IRD in the last 6 months, with a median target of $11.0.
Here are some recent targets:
- Thomas Shrader from BTIG set a target price of $12.0 on 07/06/2026
- Andreas Argyrides from Chardan Capital set a target price of $13.0 on 07/06/2026
- Matthew Caufield from HC Wainwright & Co. set a target price of $8.0 on 06/17/2026
- Jonathan Wolleben from Citizens set a target price of $11.0 on 06/15/2026
- Debjit Chattopadhyay from Guggenheim set a target price of $16.0 on 06/04/2026
- Lili Nsongo from Leerink Partners set a target price of $10.0 on 05/21/2026
- Steve Seedhouse from Cantor Fitzgerald set a target price of $15.0 on 03/30/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
